Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGL | P06737 | 5/20 | 0.41 |
| ▸ | PYGM | P11217 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | RORB | Q92753 | 2/20 | 0.40 |
| ▸ | RORC | P51449 | 1/20 | 0.40 |
| ▸ | GCK | P35557 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | BRAF | P15056 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL191586 | 0.84 | ALDH1A1 (0.56) | PYGLPYGMALDH1A1SMN1; SMN2RORB | |
| SCHEMBL26697220 | 0.82 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2RORBRORCATM | |
| SCHEMBL29738609 | 0.82 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2RORBRORCATM | |
| SCHEMBL6631074 | 0.78 | CTNNB1 (0.58) | RORBRAB9A | |
| SCHEMBL190585 | 0.73 | ALDH1A1 (0.53) | ALDH1A1RORBRORCTGFBR1 | |
| SCHEMBL28765809 | 0.72 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2ATMRAB9ACYP1A2 | |
| SCHEMBL191195 | 0.70 | KCNH2 (0.46) | ALDH1A1GCK | |
| SCHEMBL191505 | 0.69 | TSHR (0.43) | ALDH1A1GCKRAB9ACYP1A2CYP2C9 | |
| SCHEMBL202890 | 0.68 | MAPK8 (0.45) | PYGLPYGMALDH1A1GCKRAB9A | |
| SCHEMBL192020 | 0.67 | L3MBTL1 (0.64) | SMN1; SMN2GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10253001-B2 | Method for preparing azoxystrobin and its intermediates | NUTRICHEM COMPANY LIMITED (CN) | 2019-04-09 | — | — | US | disclosed |
| EP-3042896-B1 | METHODS FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF | NUTRICHEM COMPANY LTD (CN) | 2018-06-13 | — | — | EP | disclosed |
| US-20180141918-A1 | METHOD FOR PREPARING AZOXYSTROBIN AND ITS INTERMEDIATES | NUTRICHEM COMPANY LIMITED (CN) | 2018-05-24 | — | — | US | disclosed |
| US-9920015-B2 | Methods for preparing azoxystrobin and intermediate thereof | NUTRICHEM COMPANY LIMITED (CN) | 2018-03-20 | — | — | US | disclosed |
| US-20160200687-A1 | Methods for Preparing Azoxystrobin and Intermediate Thereof | SHANGYU NUTRICHEM CO., LTD. (CN) | 2016-07-14 | — | — | US | disclosed |
| EP-3042896-A1 | METHODS FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF | Nutrichem Company Limited (CN) | 2016-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160200687-A1 | Methods for Preparing Azoxystrobin and Intermediate Thereof | AZI2, CYP2B6, CYP4B1 | PYGL 2640/4885PYGM 2278/4885ALDH1A1 458/4885 |
| US-20180141918-A1 | METHOD FOR PREPARING AZOXYSTROBIN AND ITS INTERMEDIATES | AZI2, CYP2B6, CYP4B1 | PYGL 2610/4885PYGM 2140/4885ALDH1A1 663/4885 |
| US-10253001-B2 | Method for preparing azoxystrobin and its intermediates | AZI2, CYP2B6, CYP4B1 | PYGL 2610/4885PYGM 2140/4885ALDH1A1 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.